Wordt geladen...
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
Human cytomegalovirus (HCMV) is the leading cause of in utero viral infection in the United States. Since congenital HCMV infection can lead to birth defects in newborns, developing a prophylactic vaccine is a high priority. One of the early experimental vaccines, composed of a recombinant glycoprot...
Bewaard in:
| Gepubliceerd in: | NPJ Vaccines |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5730571/ https://ncbi.nlm.nih.gov/pubmed/29263890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-017-0038-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|